Lista de obras - Eva Gonzalez-Suarez - Dominio Público Uruguay

A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition

scientific article published on 08 August 2014

APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.

artículo científico publicado en 2015

Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.

artículo científico publicado en 2005

BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors

BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation

artículo científico publicado en 2007

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer

artículo científico publicado en 2017

Cancer network activity associated with therapeutic response and synergism

artículo científico publicado en 2016

Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.

artículo científico publicado en 2013

Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development

artículo científico publicado en 2002

Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs

artículo científico publicado en 2015

Evidence for a link between TNFRSF11A and risk of breast cancer

article

Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-β signaling

artículo científico publicado en 2006

FGFR inhibition overcomes resistance to EGFR-targeted therapy in epithelial-like cutaneous carcinoma

artículo científico publicado en 2020

Identification of NOG as a specific breast cancer bone metastasis-supporting gene

artículo científico publicado en 2012

Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

artículo científico publicado en 2001

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

artículo científico publicado en 2020

Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

artículo científico publicado en 2015

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

artículo científico publicado en 2016

RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis ⬇️

artículo científico publicado el 10 de abril de 2012

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.

artículo científico publicado en 2016

RANK as a therapeutic target in cancer.

artículo científico publicado en 2016

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

artículo científico publicado en 2010

RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

artículo científico publicado en 2021

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini

artículo científico publicado en 2006

RANKL inhibition: a promising novel strategy for breast cancer treatment.

artículo científico publicado en 2011

RANKL inhibitors for osteosarcoma treatment: hope and caution.

artículo científico publicado en 2016

RANKL/RANK control Brca1 mutation-driven mammary tumors

scientific article published on 31 May 2016

Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.

artículo científico publicado en 2015

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

artículo científico publicado en 2017

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

artículo científico publicado en 2016

Targeting RANKL in metastasis

artículo científico publicado en 2014

Lista de obras de Eva Gonzalez-Suarez

A Comprehensive DNA Methylation Profile of Epithelial-to-Mesenchymal Transition

APRIL promotes breast tumor growth and metastasis and is associated with aggressive basal breast cancer.

Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.

BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)- Ribose Polymerase Inhibitors

BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation

Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer

Cancer network activity associated with therapeutic response and synergism

Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.

Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development

Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs

Evidence for a link between TNFRSF11A and risk of breast cancer

Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-β signaling

FGFR inhibition overcomes resistance to EGFR-targeted therapy in epithelial-like cutaneous carcinoma

Identification of NOG as a specific breast cancer bone metastasis-supporting gene

Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells

Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk

Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness

Patient-derived xenograft (PDX) models in basic and translational breast cancer research.

RANK Induces Epithelial–Mesenchymal Transition and Stemness in Human Mammary Epithelial Cells and Promotes Tumorigenesis and Metastasis ⬇️

RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation.

RANK as a therapeutic target in cancer.

RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis

RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

RANK overexpression in transgenic mice with mouse mammary tumor virus promoter-controlled RANK increases proliferation and impairs alveolar differentiation in the mammary epithelia and disrupts lumen formation in cultured epithelial acini

RANKL inhibition: a promising novel strategy for breast cancer treatment.

RANKL inhibitors for osteosarcoma treatment: hope and caution.

RANKL/RANK control Brca1 mutation-driven mammary tumors

Rankl Impairs Lactogenic Differentiation Through Inhibition of the Prolactin/Stat5 Pathway at Midgestation.

Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Targeting RANKL in metastasis